Syngene International Ltd share price logo

Syngene International Ltd

NSE: SYNGENE

BSE: 539268

Small Cap

Healthcare Sector

₹453.50

-5.05

(-1.10%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Syngene International Stock Performance

as on June 15, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹451.30
    ₹463.80
    downward going graph

    0.49%

    Downside

    2.27%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹380.00
    ₹728.60
    downward going graph

    16.21%

    Downside

    60.66%

    Upside

    downward going graph

Syngene International share price movements today

Previous Close
₹458.55
Open
₹462.75
Volume
6.84L
Upper Circuit
₹550.25
Lower Circuit
₹366.85
Day's Low - High
₹451.30 - ₹463.80
52 Week Low - High
₹380.00 - ₹728.60

Syngene International Historical Returns

1 Month Return
-2.75 %
3 Month Return
+ 10.57 %
1 Year Return
-31.32 %
3 Year Return
-38.91 %
5 Year Return
-22.35 %

Syngene International Fundamentals

as on June 15, 2026 at 4:01 pm IST

Market Cap

₹18,306.40 Cr

Return on Equity (ROE)

10.6

PE Ratio (TTM)

57.55

Return on capital employed (ROCE)

13.04

Industry PE ratio

52.67

Beta (LTM)

0.88

P/B Ratio

6.3

Dividend Yield

0.17

PEG Ratio

-12.85

Quarterly Earnings Growth YOY

-19.31

EPS (TTM)

12.33

Book Value

117.44

Syngene International Stock Valuation

as on June 15, 2026 at 4:01 pm IST

Syngene International in the last 5 years

  • Overview

  • Trends

Lowest (23.09x)

March 31, 2020

Industry (52.67x)

June 15, 2026

Today (57.55x)

June 15, 2026

Highest (78.92x)

December 2, 2024

LowHigh

Today’s Price to Earnings Ratio: 57.55x

Syngene International Technical Analysis

Track how Syngene International technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish10
Bullish1
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
0.06
Bullish
CCI (20)
-47.88
Neutral
RSI (14)
41.55
Neutral
Momentum (10)
-0.4
Bearish
ADI (14)
15.65
Neutral
Ultimate Oscillator (7,14,28)
50.1
Neutral

Moving Averages

Name

Value

Action

SMA (20)
453.65
Bearish
EMA (20)
453.74
Bearish
VWMA (20)
453.77
Bearish
SMA (50)
453.79
Bearish
EMA (50)
453.89
Bearish
SMA (200)
455.32
Bearish
EMA (200)
454.88
Bearish
KAMA (200)
454.2
Bearish
DEMA (200)
454.26
Bearish

Syngene International Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Syngene International with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Syngene International Ltd image
Syngene International Ltd
BUY18,306.40-4.47%0.584963,642
Sanofi India Ltd image
Sanofi India Ltd
BUY7,463.33-11.64%0.004132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY81,794.298.52%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
BUY1,09,488.3214.53%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY55,791.8811.93%0.001,4146,445
See all

Market expectation of Syngene International Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

62.50%

Buy

25.00%

Hold

12.50%

Sell

Syngene International Stock’s Investor Sentiment and Interest

Investment in Syngene International Ltd Shares on INDmoney has dropped by -81.41% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-81.41% versus previous 30 day period

Search interest for Syngene International Ltd Stock has increased by 273% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:273% versus previous 30 day period

Syngene International Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
808.1
910.1
853.5
916.9
789.7
891
943.7
1,018
874.5
910.6
917.1
1,036.5
Other Income
23.6
21.6
29.3
16.1
50.1
16.5
18.3
18.9
17.7
15.4
15.4
22.2
Total Income
831.7
931.7
882.8
933
839.8
907.5
962
1,036.9
892.2
926
932.5
1,058.7
Expenses
596.2
663.4
625.7
600
619.9
646.2
660.1
674.4
668.1
711.1
778.5
739.1
Operating Profit
211.9
246.7
227.8
316.9
169.8
244.8
283.6
343.6
206.4
199.5
138.6
297.4
Operating Profit Margin %
26.22%
27.11%
26.69%
34.56%
21.5%
27.47%
30.05%
33.75%
23.6%
21.91%
15.11%
28.69%
Profit Before Interest, Tax and Depreciation
235.5
268.3
257.1
333
219.9
261.3
301.9
362.5
224.1
214.9
154
319.6
Interest
10.5
13
10.8
12.9
11.7
13.1
12.4
15.9
11.6
13.2
11.9
12.1
Depreciation
102.1
104.6
108.1
111.1
106.9
110.9
108.7
106.1
111.2
116.5
113.7
111.5
Profit Before Tax
122.9
150.7
138.2
209
101.3
137.3
180.8
240.5
101.3
85.2
28.4
196
Tax Paid
29.5
34.2
26.7
20.4
25.6
31.2
49.7
57.2
14.6
18.1
13.4
48.1
Profit After Tax
93.4
116.5
111.5
188.6
75.7
106.1
131.1
183.3
86.7
67.1
15
147.9
Total Net profit including share of profit / Loss from associate company
93.4
116.5
111.5
188.6
75.7
106.1
131.1
183.3
86.7
67.1
15
147.9
EPS
2.33
2.9
2.78
4.7
1.89
2.64
3.27
4.56
2.16
1.67
0.37
3.68
Actual EPS
2.33
2.9
2.78
4.7
1.89
2.64
3.27
4.56
2.16
1.67
0.37
3.68
Adjusted EPS
2.33
2.9
2.78
4.7
1.89
2.64
3.27
4.56
2.16
1.67
0.37
3.68
Diluted EPS
2.32
2.9
2.77
4.69
1.88
2.64
3.26
4.56
2.16
1.67
0.37
3.67

Syngene International Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
1,423.1
1,825.6
2,011.9
2,184.3
2,604.2
3,192.9
3,488.6
3,642.4
3,738.7
Other Income
61.8
75.1
152.9
99.6
52.8
70.9
90.6
103.8
70.7
Total Income
1,484.9
1,900.7
2,164.8
2,283.9
2,657
3,263.8
3,579.2
3,746.2
3,809.4
Expenses
958.3
1,288.8
1,394
1,512.5
1,838.8
2,258.5
2,485.3
2,600.6
2,896.8
Operating Profit
464.8
536.8
617.9
671.8
765.4
934.4
1,003.3
1,041.8
841.9
Operating Profit Margin %
32.66%
29.4%
30.71%
30.76%
29.39%
29.26%
28.76%
28.6%
22.52%
Profit Before Interest, Tax and Depreciation
526.6
611.9
770.8
771.4
818.2
1,005.3
1,093.9
1,145.6
912.6
Interest
22.7
32.3
34.6
27.7
24.1
45.2
47.2
53.1
48.8
Depreciation
131.4
164.2
219.3
274.5
309.7
366.5
425.9
432.6
452.9
Profit Before Tax
372.5
415.4
516.9
469.2
484.4
593.6
620.8
659.9
410.9
Tax Paid
67.1
83.8
104.8
64.3
88.6
129.2
110.8
163.7
94.2
Profit After Tax
305.4
331.6
412.1
404.9
395.8
464.4
510
496.2
316.7
Total Net profit including share of profit / Loss from associate company
305.4
331.6
412.1
404.9
395.8
464.4
510
496.2
316.7
EPS
15.47
8.39
10.38
10.18
9.94
11.59
12.71
12.35
7.87
Actual EPS
15.47
8.39
10.38
10.18
9.94
11.59
12.71
12.35
7.87
Adjusted EPS
7.74
4.2
10.38
10.18
9.94
11.59
12.71
12.35
7.87
Diluted EPS
15.43
8.36
10.35
10.11
9.82
11.51
12.69
12.34
7.87

Syngene International Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
446.2
630.4
677.1
701.2
580.6
823.5
1,042.1
1,167.6
Cash Flow from Investing Activities
-349.3
-645.5
-423.8
-628.9
-610.8
-653.3
-494.5
-744.4
Cash Flow from Financing Activities
-78.7
-72.4
-225.5
58
-31.3
-342.5
-551.4
-141.8
Net Cash Flow
18.2
-87.5
27.8
130.3
-61.5
-172.3
-3.8
281.4

Syngene International Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
54.79%
54.79%
54.79%
54.72%
54.72%
52.74%
52.74%
52.68%
52.68%
52.68%
52.68%
DII
9.94%
13.08%
15.8%
16.8%
17.48%
19.53%
21.5%
24.05%
24.62%
25.84%
26.44%
FII
0%
0%
20.92%
20.63%
20.72%
20.64%
19.47%
16.5%
16.31%
14.96%
13.9%
Public
9.46%
9.05%
8.17%
7.42%
6.74%
6.8%
6%
6.45%
6.08%
6.22%
6.69%
Total Outstanding Shares
40,20,15,000
40,20,15,000
40,20,15,000
40,25,36,981
40,25,36,981
40,25,36,981
40,25,36,981
40,29,39,420
40,29,39,420
40,29,39,420
40,29,39,420
Total Shareholders
1,25,992
1,21,880
1,15,850
1,20,018
1,07,338
1,28,806
1,25,090
1,42,310
1,36,061
1,31,750
1,35,605

Mutual Funds that own Syngene International Stock

Check out the Mutual Funds with significant holdings in Syngene International.

Syngene International Corporate Actions

View detailed summary of the earnings and dividend history of Syngene International.

  • Syngene International Ltd Earnings Results

    Syngene International Ltd’s net profit fell -19.31% since last year same period to ₹147.90Cr in the Q4 2025-2026. On a quarterly growth basis, Syngene International Ltd has generated 886% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Syngene International Ltd Dividends April,2026

    In the quarter ending March 2026, Syngene International Ltd has declared dividend of ₹1.25 per share on 29 Apr 2026 - translating a dividend yield of 0.27%.

    Read More about Dividends

Indices Featuring Syngene International Stock

Check stock indices that include Syngene International.

Nifty Healthcare

₹15,488.55

-0.41 (▲63.15%)

Nifty Smallcap 250

₹17,292.70

1.25 (▲213.60%)

S&P BSE 250 SmallCap

₹6,891.58

1.38 (▲93.57%)

BSE Healthcare

₹47,164.40

-0.47 (▲223.87%)

S&P BSE SmallCap Select

₹8,518.76

1.00 (▲84.35%)

BSE 500

₹35,764.67

1.19 (▲422.17%)

Nifty Smallcap 50

₹9,073.50

1.09 (▲97.40%)

S&P BSE 400 MidSmallCap

₹12,294.91

1.44 (▲174.14%)

Nifty Small 100

₹18,400.00

1.11 (▲202.55%)

Nifty MidSmallcap 400

₹20,645.60

1.40 (▲284.15%)

Nifty 500

₹22,891.30

1.29 (▲291.50%)

Insights on Syngene International Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 22.71% to 24.18% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 892.2 Cr → 1.05K Cr (in ₹), with an average increase of 5.4% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 6.22% to 6.69% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 15.0 Cr → 147.9 Cr (in ₹), with an average increase of 89.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 164.6% return, outperforming this stock by 203.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 52.68% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Biocon Ltd has given 17.3% return, outperforming this stock by 47.8%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 14.96% to 13.90% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, SYNGENE stock has moved down by -30.6%

About Syngene International Ltd

Syngene International Limited is a India-based research, development, and manufacturing services organization driven by a team of 5200 scientists. It focuses primarily on the pharmaceutical and biotechnology sectors, and also provides services for nutrition, animal health, consumer goods, and other chemical sectors. The company’s health-related services extends across all major therapy areas and modalities. The operations are spread across 2 million sq. ft. with facilities at Bangalore, Hyderabad, and Mangalore. Syngene International Limited was incorporated in 1993 and consistently has entered into partnerships for research and development. This helped Syngene International cross an annual turnover of Rs 1000 crore in the year 2016. Over the years leading up to 2021, Syngene International expanded its research collaboration with companies such as Abbott, Bristol Myers Squibb, Herbalife, and Glaxo Smith Kline. It also commissioned new facilities and added bioreactors and microbial manufacturing capacity to strengthen biologics manufacturing. With investments in R&D and strengthening scientific capabilities, Syngene International continues to provide integrated drug discovery services.

Revenue: ₹1,036.50Cr as on March 2026 (Q4 FY26)
Net Profit: ₹147.90Cr as on March 2026 (Q4 FY26)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
OrganisationSyngene International Ltd
IndustryHealthcare
CEOKiran Mazumdar Shaw
E-voting on sharesClick here to vote

FAQs

What is Syngene International share price today?

Syngene International share price today stands at ₹453.5 as on . Syngene International share today touched a day high of ₹463.8 and a low of ₹451.3.

What is the 52 week high and 52 week low range for Syngene International share?

Syngene International touched a 52 week high of ₹728.6 and a 52 week low of ₹380. Syngene International share price today i.e. is trending at ₹453.5, which is -37.76% down from its 52 week high and 19.34% up from its 52 week low.

What is Syngene International's market capitalisation today?

Syngene International market capitalisation is ₹18,306.40 Cr as on .

How to buy Syngene International shares?

To buy Syngene International shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SYNGENE or Syngene International Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Syngene International shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Syngene International trading volume today?

Syngene International trading volume is 6.84L as on . This means that 6.84L shares of Syngene International were bought and sold on the stock market during today's trading session.